Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole + celecoxib for metastatic hormone receptor-positive postmenopausal breast cancer
ACTRN12605000498695Phase 2Active, not recruiting
- Sponsor
- Royal Adelaide Hospital
- Start
- Jun 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of anastrozole and celecoxib in breast cancer, sponsored by Royal Adelaide Hospital. Primary endpoint: Objective response rate. Started Jun 2005; status: active, not recruiting.
02
Drugs
anastrozolecelecoxib
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12605000498695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000498695.